PROM Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about PROM clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 1

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

SarcomaPrecursor Cell Lymphoblastic Leukemia-LymphomaNeurofibroma, Plexiform+1 more
National Cancer Institute (NCI)54 enrolled1 locationNCT02390752
Recruiting
Phase 2

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

COVID-19Inflammatory Bowel DiseaseRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre660 enrolled3 locationsNCT06599658
Recruiting
Phase 2

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia With PML-RARA
M.D. Anderson Cancer Center151 enrolled5 locationsNCT01409161
Recruiting
Phase 2

Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma With Prominent Nucleoli (SBLPN): A Prospective, Open-label, Single-arm Clinical Trial

Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli,SBLPN
Institute of Hematology & Blood Diseases Hospital, China47 enrolled1 locationNCT07165769
Recruiting

Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firsT Line settIng Non- Small-Cell Lung Cancer (NSCLC) According to Chemo- Immunotherapy reGimen

PROMs
IRCCS San Raffaele144 enrolled1 locationNCT07061379
Recruiting
Phase 2

Frontline Oral Arsenic Trioxide for APL

Acute Promyelocytic Leukemia
The University of Hong Kong100 enrolled2 locationsNCT04687176
Recruiting
Phase 2

Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia (APL)
Instituto do Cancer do Estado de São Paulo115 enrolled1 locationNCT06982274
Recruiting
Not Applicable

DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer

Breast CancerProstate CancerCancer+2 more
Lauren Hamel260 enrolled1 locationNCT04766190
Recruiting

Compliance With ERAS Protocol in Pancreatic Surgery, Stress Response and Outcomes

PROMsPancreas CancerERAS+4 more
University of Thessaly120 enrolled1 locationNCT05518643
Recruiting
Not Applicable

Danish Vulva Cancer Recurrence Study

SurvivorshipCirculating Tumor DNAVulvar Cancer+6 more
University of Aarhus1,295 enrolled2 locationsNCT06495554
Recruiting
Not Applicable

Physiological and Psychological Effects of Music Therapy in the Pregnant Woman and Fetus

Music TherapyPreterm Premature Rupture of Membrane (PPROM)
Christina Chianis Reed60 enrolled1 locationNCT05893485
Recruiting
Not Applicable

Optimum Induction Therapy of Low-risk APL

Acute Promyelocytic LeukemiaInduction TherapyOral
Peking University People's Hospital74 enrolled1 locationNCT05832320
Recruiting
Phase 2

Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia
Associazione Italiana Ematologia Oncologia Pediatrica89 enrolled31 locationsNCT04793919
Recruiting

RWE of 1st Line Treatment With ATO/ATRA for Adult APL

Promyelocytic Leukemia, Adult Acute
Grupo Argentino de Tratamiento de la Leucemia Aguda50 enrolled6 locationsNCT04897490
Recruiting
Not Applicable

Partial Breast Versus no Irradiation for Women With Early Breast Cancer

Local Neoplasm RecurrenceDistantly Metastatic Malignant NeoplasmDeath+6 more
Danish Breast Cancer Cooperative Group926 enrolled17 locationsNCT03646955